Vendor and Supplier Qualification Program for FDA Regulated Industries Vendor and Supplier Qualification Program for FDA Regulated Industries Seminar has been added to ComplianceOnline.com s offering.
SAN JOSE, CALIFORNIA, UNITED STATES, April 19, 2021 /EINPresswire.com/ ComplianceOnline, the world’s leading provider of training for regulated companies will hold a virtual seminar entitled ‘Vendor and Supplier Qualification Program for FDA Regulated Industries.’ The seminar which will be presented by Joy McElroy, will help attendees establish and manage a program that is FDA compliant and robust.
The FDA regulates manufacturers of medical products such as devices, pharmaceuticals, tissue products, and biologics. However, the regulations don’t usually extent to suppliers. Instead, the FDA expects the medical product manufacturer to implement an effective program to qualify and re-qualify suppliers for these regulated industries.
Share this article
Share this article
ResearchAndMarkets.com s offering.
The global connected drug delivery devices market size is expected to reach USD 4.07 billion by 2028 registering a CAGR of 46.7%
Factors contributing to the growth of this market include a rise in awareness about the adverse effects of non-adherence to medication and increased adoption of IoT, patient connectivity, and engagement. The Covid-19 pandemic has further accentuated the need for contactless services, thereby increasing the demand for connected drug delivery devices as well as providing lucrative growth opportunities in the coming years.
Connected drug delivery devices help physicians to monitor the compliance of patients to the therapy prescribed by them as well as to modify the treatment of the patient treatment as required. A growing number of initiatives to create awareness regarding the complexities caused by overdosage or underdosage of medicines is expected to promote the adoption of conn
Search jobs 01-Mar-2021 Global Connected Drug Delivery Devices (Bluetooth, NFC, Other) Market Size, Share & Trends Analysis Report 2021-2028 - ResearchAndMarkets.com
ResearchAndMarkets.com s offering.
The global connected drug delivery devices market size is expected to reach USD 4.07 billion by 2028 registering a CAGR of 46.7%
Factors contributing to the growth of this market include a rise in awareness about the adverse effects of non-adherence to medication and increased adoption of IoT, patient connectivity, and engagement. The Covid-19 pandemic has further accentuated the need for contactless services, thereby increasing the demand for connected drug delivery devices as well as providing lucrative growth opportunities in the coming years.
Some of the major factors driving the growth of the Drug Delivery Equipment market are the rise in the geriatric population, as well as collaborations and partnerships, to facilitate drug development. Additionally, the increase in healthcare expenditure has significantly contributed to market growth. An increase in the number of pipeline drugs and huge growth potential from emerging economies are more likely to provide lucrative opportunities for the market to expand.
The end users/applications and product categories analysis:
On the basis of product, this report displays the sales volume, revenue (Million USD), product price, market share and growth rate of each type, primarily split into-
Global Medical Injection Molding Market 2020 Outlook, Current and Future Industry Landscape Analysis 2025 newyorktelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newyorktelegraph.com Daily Mail and Mail on Sunday newspapers.